======= RTFDC1 ======= == Gene Information == * **Official Symbol**: RTF2 * **Official Name**: replication termination factor 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=51507|51507]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9BY42|Q9BY42]] * **Interactions**: [[https://thebiogrid.org/search.php?search=RTFDC1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20RTFDC1|Open PubMed]] * **OMIM**: N/A == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: N/A |Rtf2| |site-specific DNA replication termination| |genetic imprinting at mating-type locus| |cell cycle DNA replication termination| |mitotic DNA replication termination| |DNA replication termination| |nuclear DNA replication termination| |establishment of imprinting at mating-type locus| |site-specific DNA replication termination at RTS1 barrier| |regulation of mating type switching| |regulation of DNA stability| |mitotic DNA replication| |cellular response to hydroxyurea| |response to hydroxyurea| |response to antimetabolite| |genetic imprinting| |replication fork| |regulation of cell fate commitment| |nuclear DNA replication| |cell cycle DNA replication| |response to antineoplastic agent| |DNA-dependent DNA replication| |regulation of reproductive process| |DNA replication| |cellular response to inorganic substance| |cellular response to drug| |response to inorganic substance| |mitotic cell cycle process| |cellular response to nitrogen compound| |mitotic cell cycle| |DNA metabolic process| |molecular function| |cell cycle process| |response to drug| |response to nitrogen compound| |cell cycle| |DNA binding| |cellular macromolecule biosynthetic process| |macromolecule biosynthetic process| |regulation of cell differentiation| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp264|Arsenate 40μM R06 exp264]]|-2.76| |[[:results:exp282|Fluvastatin 2.2μM R06 exp282]]|-2.15| |[[:results:exp260|ABT-702 0.1μM R06 exp260]]|-1.85| |[[:results:exp242|Radicicol 0.16μM R05 exp242]]|-1.83| |[[:results:exp299|Talazoparib 0.006μM R06 exp299]]|-1.81| |[[:results:exp433|LJH685 50μM R08 exp433]]|-1.76| |[[:results:exp79|Q15 2.7μM R02 exp79]]|-1.76| |[[:results:exp472|CI-1040 9.5μM R08 exp472]]|-1.75| |[[:results:exp290|LLY-283 2.6μM R06 exp290]]|-1.7| |[[:results:exp40|2-Methoxyestradiol 0.2μM R01 exp40]]|1.81| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 143/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|7/28| |blood|10/28| |bone|7/26| |breast|5/33| |central nervous system|17/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|2/21| |liver|4/20| |lung|16/75| |lymphocyte|4/16| |ovary|5/26| |pancreas|3/24| |peripheral nervous system|4/16| |plasma cell|7/15| |prostate|0/1| |skin|1/24| |soft tissue|2/9| |thyroid|0/2| |upper aerodigestive|1/22| |urinary tract|6/29| |uterus|2/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1105 * **Expression level (log2 read counts)**: 5.84 {{:chemogenomics:nalm6 dist.png?nolink |}}